SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

US FDA Greenlights Viridian's Thyroid Eye Disease Drug

The U.S. Food and Drug Administration has approved Viridian Therapeutics' drug to treat patients with thyroid eye disease, the ⁠company said on Friday.

FDA Set to Review Sandoz's Generic GLP-1s

The U.S. Food and Drug Administration has agreed to review ⁠Swiss generics drugmaker Sandoz's two generic tirzepatide GLP-1s that, if approved, would rival ⁠obesity drugs...

Many Eating Disorder Patients Using GLP-1s

With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for disordered eating before prescribing.

Asthma-Diabetes Combo Linked to Poor Metabolic Health

Patients with both asthma and diabetes have more adverse cardiometabolic and inflammatory biomarker profiles than those with neither condition, a cross-sectional study shows.

PCOS Rename? Critics Say PMOS Misses the Mark

While most experts agree that PCOS needed a new name, some participants at ENDO 2026 questioned both the new PMOS terminology and the process used to develop it.

When a Kid’s Bad Behavior Is Actually Hidden Sleep Disorder

In children, the effects of sleep problems may be even more pronounced than in adults because sleep is closely tied to growth, learning, and brain maturation.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Latest News

The U.S. Food and Drug Administration has approved Viridian Therapeutics' drug to treat patients with thyroid eye disease, the ⁠company said on Friday.

The U.S. Food and Drug Administration has agreed to review ⁠Swiss generics drugmaker Sandoz's two generic tirzepatide GLP-1s that, if approved, would rival ⁠obesity drugs...

With over 30% of eating disorder patients utilizing GLP-1 medications, experts urge primary care clinicians to screen for disordered eating before prescribing.

Patients with both asthma and diabetes have more adverse cardiometabolic and inflammatory biomarker profiles than those with neither condition, a cross-sectional study shows.

While most experts agree that PCOS needed a new name, some participants at ENDO 2026 questioned both the new PMOS terminology and the process used to develop it.

In children, the effects of sleep problems may be even more pronounced than in adults because sleep is closely tied to growth, learning, and brain maturation.

News All Time

China Approval for Eli Lilly GLP-1 Pill to Come as Soon as 2026, Executive Says

Eli Lilly's orforglipron type-2 diabetes and obesity pill could launch in China as soon ⁠as later this year, an executive at the U.S. drugmaker told Reuters, as rival Novo...

Urogenital Infections Tied to SGLT2 Therapy Discontinuation

Patients with type 2 diabetes who start SGLT2 inhibitors and then develop a urinary or genital tract infection are more likely to discontinue treatment than matched patients without an infection.

Fasting and Calorie Restriction Work via Different Pathways

In adults with obesity, both intermittent fasting and calorie restriction lead to significant weight loss but act through distinct behavioral pathways.

Protein Source Key for Weight Loss After Menopause

Postmenopausal women are often encouraged to eat more protein, but a new study finds that protein source matters, with plant-based protein outperforming animal protein for weight loss.

What GLP-1s Are Teaching Us About Compulsive Behavior

As GLP-1 research moves deeper into the brain, scientists are asking whether these drugs can help explain why some urges become so hard to resist.

NHS Recommends First Drug to Delay Type 1 Diabetes

NICE has recommended teplizumab — the first medicine to delay type 1 diabetes onset — in what Diabetes UK calls ‘a new age of treatment.’

GLP-1s Tied to Reduced Opioid Use in Chronic Pancreatitis

Among patients with chronic pancreatitis, GLP‑1 treatment is associated with a lower likelihood of initiating long-term opioid therapy or developing opioid use disorder.

GLP-1 Era Demands a New Model of Obesity Care

Panelists at HLTH Europe 2026 say obesity care must shift to lifelong digital models and shed its stigma as a moral failing.

Erosive Hand OA Flags Fracture Risk in Postmenopausal Women

Erosive hand osteoarthritis is associated with an increased risk for incident osteoporotic fractures in postmenopausal women, a study finds.

Medicare to Cover New Osteoporosis Diagnostic Screening Test

Medicare coverage of a new osteoporosis screening tool may help to address the challenge of identifying and treating patients with osteoporosis by expanding access to screening.

10-Hour Eating Window Boosts Weight Loss in Obesity

10-hour time-restricted eating promotes greater weight loss and improved body composition in adults with obesity and without diabetes than standard dietary counseling alone.

US Health Department Proposes Testosterone Therapy Label Updates

The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data ⁠and other...

The HPV Vaccine at 20: Progress Made, Challenges Ahead

Evidence supports HPV vaccination as a powerful cancer prevention tool, but improving its uptake remains critical for achieving long-term public health goals.

AGA Updates POWER Guide for Obesity, Weight Management

Updated guidance from the American Gastroenterological Association aims to help clinicians navigate the growing number of obesity and weight-management treatment options.

Breast Cancer Patients Taking GLP-1s Had Better Survival

The findings from a large observational study underscore the need for randomized clinical trials to assess the relationship between GLP-1 use and outcomes in patients with cancer.

MRI Predicts Survival Better Than Pathology in Rectal Cancer

MRI provides a more reliable preoperative prediction of survival and recurrence in patients with rectal tumour than traditional histopathology.

Recommended News For You

Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.

La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.

For MDS-Related Anemia, Telomerase Inhibitor Approved.

FDA Authorizes Three Different Uses for Injectable Antibiotic.

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

Discovery reveals protein involved in Parkinson's disease also drives skin cancer

An understudied type of breast cancer poses a lurking threat

Recommended Articles For You

Machine Learning for Bone Marrow Ecosystem Analysis 

Decoding Granular Cell Tumor: What You Need to Know 

Unraveling the Mysteries of Hematocrit: How It Impacts Your Health 

Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

2.

Infection Burden High With Myeloma T-Cell Therapies

3.

Capivasertib Wins Metastatic Prostate Cancer Approval

4.

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

5.

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

1.

Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being

2.

Practical Directions in Oncology in Daily Practice

3.

Neutrophil Profiling and AI Rewrites Cancer Diagnosis

4.

The Importance of Iron Rich Foods in Preventing and Treating Anemia 

5.

Emerging Insights in Hematology for Better Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Navigating the Complexities of Ph Negative ALL - Part XV

2.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

3.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot